We extracted genomic
DNA from whole blood samples obtained from breast
cancer patient volunteers and compared the results of the
product obtained in terms of quantity (concentration of
DNA extracted and DNA obtained per ml of blood used)
and quality (260/280 ratio and polymerase chain reaction
product amplification) of the obtained yield.